Scarica l'app Stockscreener
11.23
3.19%
-0.3554
Precedente Chiudi:
$11.59
Aprire:
$11.68
Volume 24 ore:
298.04K
Relative Volume:
0.19
Capitalizzazione di mercato:
$527.88M
Reddito:
$217.11M
Utile/perdita netta:
$-651.19M
Rapporto P/E:
-0.8649
EPS:
-12.99
Flusso di cassa netto:
$-387.26M
1 W Prestazione:
-7.96%
1M Prestazione:
-30.48%
6M Prestazione:
+62.14%
1 anno Prestazione:
+40.43%
Intervallo 1D:
$11.19
$11.68
Intervallo di 1 settimana:
$11.22
$13.18
Portata 52W:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Nome
Ginkgo Bioworks Holdings Inc
Settore
Industria
Telefono
(877) 442-5362
Indirizzo
27 DRYDOCK AVENUE, BOSTON
Confronta DNA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
11.21 | 686.13M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
419.22 | 107.10B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
631.95 | 66.00B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.57 | 55.95B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
827.15 | 51.19B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.67 | 38.98B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-15 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-05-10 | Downgrade | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-02 | Downgrade | Goldman | Neutral → Sell |
| 2023-05-11 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Iniziato | Berenberg | Buy |
| 2022-10-04 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Ripresa | Cowen | Outperform |
| 2022-02-23 | Iniziato | Goldman | Neutral |
| 2022-02-01 | Iniziato | BofA Securities | Neutral |
| 2022-01-28 | Iniziato | BofA Securities | Buy |
| 2022-01-07 | Iniziato | BTIG Research | Buy |
| 2021-11-29 | Iniziato | Jefferies | Buy |
| 2021-10-13 | Iniziato | Raymond James | Outperform |
| 2021-10-12 | Iniziato | William Blair | Outperform |
| 2021-09-20 | Iniziato | HSBC Securities | Buy |
Mostra tutto
Ginkgo Bioworks Holdings Inc Borsa (DNA) Ultime notizie
Earnings To Watch: Ginkgo Bioworks Holdings Inc (DNA) Reports Q3 2025 Result - GuruFocus
Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyBreakout Watch & Daily Chart Pattern Signal Reports - newser.com
Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Market Trend Summary & High Accuracy Investment Signals - newser.com
Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainable2025 Price Targets & Real-Time Price Movement Reports - newser.com
Ginkgo Bioworks Holdings Inc. stock daily chart insights2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strengthJuly 2025 Setups & Free Weekly Chart Analysis and Trade Guides - newser.com
Live market analysis of Ginkgo Bioworks Holdings Inc.Trade Volume Report & Safe Entry Zone Identification - newser.com
How interest rate cuts could boost Ginkgo Bioworks Holdings Inc. stockPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Exit strategy if you’re trapped in Ginkgo Bioworks Holdings Inc.2025 Dividend Review & Entry Point Confirmation Signals - newser.com
Ginkgo Bioworks Holdings, Inc. $DNA Shares Sold by AlphaQuest LLC - MarketBeat
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedWeekly Stock Report & High Yield Stock Recommendations - newser.com
Ginkgo Bioworks Wins Project Agreement Through BARDA's BioMaP-Cons Consortium - MarketScreener
Published on: 2025-11-05 03:59:54 - newser.com
Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockBond Market & Safe Capital Investment Plans - newser.com
Ginkgo (NYSE: DNA) awarded $22.2M BARDA BioMaP project to cut mAb manufacturing costs - Stock Titan
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture - MarketScreener
Will Ginkgo Bioworks Holdings Inc. continue its uptrendGap Down & Verified Stock Trade Ideas - newser.com
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarterWeekly Trend Report & Daily Chart Pattern Signals - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat
Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Pre - GuruFocus
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.2%Here's What Happened - MarketBeat
Using Python tools to backtest Ginkgo Bioworks Holdings Inc. strategiesInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock split2025 Volatility Report & Safe Capital Growth Plans - newser.com
Ginkgo Bioworks stock surges after extending Bayer partnership By Investing.com - Investing.com Canada
Ginkgo Bioworks, Bayer extend partnership for agricultural biologicals By Investing.com - Investing.com Canada
Ginkgo Bioworks Holdings Inc Azioni (DNA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.52%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):